Company Filing History:
Years Active: 2012
Title: Michael Mosebach - Innovator in Pharmaceutical Chemistry.
Introduction
Michael Mosebach is a notable inventor in the field of pharmaceutical chemistry. He has contributed to the development of methods that enhance the reliability and reproducibility of chemical preparations. His work is particularly significant in the context of solid pharmaceutical forms.
Latest Patents
Michael Mosebach holds a patent for a method titled "Method For Preparing 4-[17.beta.-Methoxy-17.alpha.-Methoxymethyl-3-Oxoestra-4,9-Dien-11.beta.-Yl]benzaldehyde (e)-Oxime (asoprisnil)." This invention relates to a method for the reliable and reproducible preparation of asoprisnil on both pilot and manufacturing scales. The asoprisnil produced by this method is characterized by excellent physical stability, making it particularly suitable for the manufacture of solid pharmaceutical forms such as tablets and coated tablets.
Career Highlights
Throughout his career, Michael Mosebach has focused on innovations that improve pharmaceutical manufacturing processes. His expertise in chemical synthesis has positioned him as a valuable contributor to the field.
Collaborations
Michael has collaborated with notable colleagues, including Detlef Grawe and Sabine Gliesing. Their joint efforts have further advanced the research and development of pharmaceutical compounds.
Conclusion
Michael Mosebach's contributions to pharmaceutical chemistry, particularly through his patented method for preparing asoprisnil, highlight his role as an innovator in the industry. His work continues to influence the development of stable pharmaceutical formulations.